{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:21:04Z","timestamp":1787167264341,"version":"build-2736575974"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12185-025-04053-6","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T07:04:32Z","timestamp":1755241472000},"page":"104-112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Validation of an algorithm for identifying patients with febrile neutropenia: an epidemiological study using real-world data in Japan"],"prefix":"10.1007","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2502-6955","authenticated-orcid":false,"given":"Kazuhiro","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyoshi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi Benjamin","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,15]]},"reference":[{"issue":"Suppl 1","key":"4053_CR1","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1086\/383050","volume":"39","author":"J Klastersky","year":"2004","unstructured":"Klastersky J. Management of fever in neutropenic patients with different risks of complications. Clin Infect Dis. 2004;39(Suppl 1):S32\u20137.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"4053_CR2","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):e56-93.","journal-title":"Clin Infect Dis"},{"issue":"suppl 5","key":"4053_CR3","doi-asserted-by":"publisher","first-page":"v111","DOI":"10.1093\/annonc\/mdw325","volume":"27","author":"J Klastersky","year":"2016","unstructured":"Klastersky J, et al. Management of febrile neutropaenia: ESMO clinical practice guidelines. Ann Oncol. 2016;27(suppl 5):v111\u20138.","journal-title":"Ann Oncol"},{"key":"4053_CR4","unstructured":"Clinical practice guidelines for febrile neutropenia (3rd edition, revised). Japanese Society of Medical Oncology (JSMO) . 2023; Available from: https:\/\/www.jsmo.or.jp\/news\/jsmo\/20231109.html. Accessed 14 Aug 2025"},{"issue":"3","key":"4053_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.7888\/juoeh.36.191","volume":"36","author":"H Yasunaga","year":"2014","unstructured":"Yasunaga H, et al. Application of the diagnosis procedure combination (DPC) data to clinical studies. J UOEH. 2014;36(3):191\u20137.","journal-title":"J UOEH"},{"issue":"8","key":"4053_CR6","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.jiac.2021.03.004","volume":"27","author":"K Matsuda","year":"2021","unstructured":"Matsuda K, et al. Difference of preventing effects of G-CSF according to age in patients with malignant lymphoma: a nation-wide analysis in Japan. J Infect Chemother. 2021;27(8):1151\u20135.","journal-title":"J Infect Chemother"},{"key":"4053_CR7","unstructured":"Us_Fda, Real-world data: assessing electronic health records and medical claims data to support regulatory decision-making for drug and biological products | FDA. 2024."},{"issue":"1","key":"4053_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2188\/jea.JE20200288","volume":"31","author":"K Hayashida","year":"2021","unstructured":"Hayashida K, et al. History and profile of diagnosis procedure combination (DPC): development of a real data collection system for acute inpatient care in Japan. J Epidemiol. 2021;31(1):1\u201311.","journal-title":"J Epidemiol"},{"key":"4053_CR9","unstructured":"National Cancer Center Japan. Latest cancer statistics [Internet]. 2024 [cited 2025 Mar 27]. Available from: https:\/\/ganjoho.jp\/reg_stat\/statistics\/stat\/summary.html. Accessed 14 Aug 2025"},{"issue":"8","key":"4053_CR10","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00045-21","volume":"65","author":"A Albasanz-Puig","year":"2021","unstructured":"Albasanz-Puig A, et al. Impact of the inclusion of an aminoglycoside to the initial empirical antibiotic therapy for Gram-negative bloodstream infections in hematological neutropenic patients: a propensity-matched cohort study (AMINOLACTAM study). Antimicrob Agents Chemother. 2021;65(8): e0004521.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"4053_CR11","doi-asserted-by":"publisher","first-page":"106331","DOI":"10.1016\/j.jinf.2024.106331","volume":"89","author":"J Zhou","year":"2024","unstructured":"Zhou J, et al. Clinical characteristics and prognosis of bloodstream infections with carbapenem-resistant Gram-negative organisms in patients with hematological malignancies: a multicenter case-control study in China. J Infect. 2024;89(6):106331.","journal-title":"J Infect"},{"key":"4053_CR12","unstructured":"Japan Nosocomial Infections Surveillance (JANIS), Ministry of health, labour and welfare 2024; Available from: https:\/\/janis.mhlw.go.jp\/. Accessed 14 Aug 2025"},{"issue":"1","key":"4053_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12941-020-00348-0","volume":"19","author":"W Mimura","year":"2020","unstructured":"Mimura W, Fukuda H, Akazawa M. Antimicrobial utilization and antimicrobial resistance in patients with haematological malignancies in Japan: a multi-centre cross-sectional study. Ann Clin Microbiol Antimicrob. 2020;19(1):7.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"3","key":"4053_CR14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s15010-021-01753-z","volume":"50","author":"T Hattori","year":"2022","unstructured":"Hattori T, et al. Predictive value of surveillance cultures for bacteremia caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales among patients with hematological diseases. Infection. 2022;50(3):753\u20139.","journal-title":"Infection"},{"key":"4053_CR15","doi-asserted-by":"publisher","DOI":"10.1159\/000546029","author":"Y Nadir","year":"2025","unstructured":"Nadir Y, et al. Determining the cut-off value of the MASCC Score to predict mortality in hospitalized febrile neutropenic patients: A decade-long single-center retrospective cohort study. Oncology. 2025. https:\/\/doi.org\/10.1159\/000546029.","journal-title":"Oncology"},{"key":"4053_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12175635","author":"H Shmuely","year":"2023","unstructured":"Shmuely H, Monely L, Shvidel L. All-cause mortality and its predictors in haemato-oncology patients with febrile neutropenia. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12175635.","journal-title":"J Clin Med"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04053-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-025-04053-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04053-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:02:34Z","timestamp":1768834954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-025-04053-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4053"],"URL":"https:\/\/doi.org\/10.1007\/s12185-025-04053-6","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}